| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2078159 | Cell Stem Cell | 2008 | 6 Pages |
Abstract
Centralized banking of human embryonic stem (hES) cells is an endeavor that can benefit individual research efforts and enhance international collaboration but is complicated by the fact that the science is rapidly evolving in an environment of heterogeneous laws, guidelines, and ethical standards. Written from the vantage point of regulatory professionals, this article provides an overview of the benefits of and challenges facing hESC banking enterprises in general with a focus on a global centralized banking effort.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
P. Pearl O'Rourke, Melinda Abelman, Kate Gallin Heffernan,